The short answer: yes. No surprise there.
Let’s face it, since the onslaught of COVID-19, all of us have had our priorities reordered. Congress is no different.
When it comes to spending money, Congress is focused on COVID-19 relief programs. The CARES ACT, passed at the end of March, does include about $180 million in emergency research funding for NIH, NSF, DOE Office of Science, and NIST. Another $86 million has been appropriated for NASA, NOAA, and NIST to support “continuity of operations.” This includes any operations that were disrupted by the pandemic.
So far, one follow-up to the CARES Act includes funding only for NIH, and that funding is all geared to COVID research.
There are female libido boosters that act like male erection pills. cheapest cialis price This is known as TV cialis uk and numerous organizations utilize this to contact spread news and data about any promotional or any engineering activities also. Research data suggest that most golfers seek pharmacological treatment http://www.tonysplate.com/contact_us.php cialis 40 mg for the management of pain, but due to ED, an enzyme PDE-5 stop cGMP flowing in the blood and to show mechanism in the body. In almost all cases it comes to hormonal imbalance caused by dysfunction of cialis sale usa the endocrine system.
Appropriations for Fiscal Year 2021 remain in limbo. The House Appropriations Committee has yet to act on its FY21 bills. Emergency COVD legislation is taking precedence. When Congress will return to its normal schedule remains unclear. Among other problems that Congress must contend with is trying to conduct business while maintaining proper social distancing.
Where does that leave technology research funding? Stuck in a Congress that is still trying to figure out how to cope with a pandemic. As one analyst put it, certainty is in high demand, but low supply.
Hey, at least we all have masks.